Emi Takashita

5.5k total citations
76 papers, 2.7k citations indexed

About

Emi Takashita is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Emi Takashita has authored 76 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Epidemiology, 27 papers in Infectious Diseases and 12 papers in Molecular Biology. Recurrent topics in Emi Takashita's work include Influenza Virus Research Studies (64 papers), Respiratory viral infections research (59 papers) and Viral Infections and Immunology Research (12 papers). Emi Takashita is often cited by papers focused on Influenza Virus Research Studies (64 papers), Respiratory viral infections research (59 papers) and Viral Infections and Immunology Research (12 papers). Emi Takashita collaborates with scholars based in Japan, United States and United Kingdom. Emi Takashita's co-authors include Seiichiro Fujisaki, Yoko Matsuzaki, Masato Tashiro, Yoshihiro Kawaoka, Yasushi Muraki, Kanetsu Sugawara, Takato Odagiri, Gabriele Neumann, Seiji Hongō and S. Yamada and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Emi Takashita

75 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emi Takashita Japan	29	2.4k	777	562	467	355	76	2.7k
Yoko Matsuzaki Japan	31	2.0k 0.8×	1.2k 1.6×	539 1.0×	426 0.9×	327 0.9×	106	2.8k
Yuko Sakai‐Tagawa Japan	22	1.7k 0.7×	820 1.1×	445 0.8×	351 0.8×	425 1.2×	46	2.2k
Pui Wang Hong Kong	21	1.1k 0.5×	746 1.0×	537 1.0×	439 0.9×	285 0.8×	38	1.8k
Seiya Yamayoshi Japan	26	1.3k 0.5×	1.3k 1.6×	978 1.7×	481 1.0×	450 1.3×	108	2.8k
Wenjun Song China	23	1.0k 0.4×	706 0.9×	550 1.0×	379 0.8×	332 0.9×	52	1.9k
Kemin Xu United States	14	1.6k 0.7×	1.5k 2.0×	293 0.5×	289 0.6×	870 2.5×	17	2.5k
Lucy A. Perrone United States	15	1.5k 0.6×	745 1.0×	326 0.6×	1.1k 2.3×	338 1.0×	33	2.3k
Connie Y. H. Leung Hong Kong	26	2.3k 1.0×	1.6k 2.1×	279 0.5×	502 1.1×	1.4k 4.0×	43	3.2k
Yun Hee Baek South Korea	23	1.0k 0.4×	984 1.3×	416 0.7×	226 0.5×	452 1.3×	59	1.8k
Henju Marjuki United States	19	1.3k 0.5×	498 0.6×	432 0.8×	590 1.3×	246 0.7×	43	1.7k

Countries citing papers authored by Emi Takashita

Since Specialization

Citations

This map shows the geographic impact of Emi Takashita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Takashita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Takashita more than expected).

Fields of papers citing papers by Emi Takashita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emi Takashita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Takashita. The network helps show where Emi Takashita may publish in the future.

Co-authorship network of co-authors of Emi Takashita

This figure shows the co-authorship network connecting the top 25 collaborators of Emi Takashita. A scholar is included among the top collaborators of Emi Takashita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emi Takashita. Emi Takashita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Kaixin, Akiko Takenaka‐Uema, Emi Takashita, et al.. (2025). Seroprevalence of influenza C and D virus infections among cattle in Japan. Veterinary and Animal Science. 29. 100468–100468.

Takashita, Emi, Kanju Saka, Hiroko Morita, et al.. (2025). Impact of the polymerase acidic protein E199K substitution in influenza A viruses on baloxavir susceptibility. Antiviral Research. 239. 106173–106173. 1 indexed citations

Takashita, Emi, Masataka Ichikawa, Seiichiro Fujisaki, et al.. (2024). Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infected pediatric patients. International Journal of Infectious Diseases. 146. 107134–107134. 1 indexed citations

Sato, Masatoki, Emi Takashita, Masahiko Katayose, et al.. (2023). Clinical and Virologic Impacts of Respiratory Viral Co-infections in Children With Influenza. The Pediatric Infectious Disease Journal. 42(8). e268–e273. 2 indexed citations

Takashita, Emi, Shinji Watanabe, Hideki Hasegawa, & Yoshihiro Kawaoka. (2022). Are twindemics occurring?. Influenza and Other Respiratory Viruses. 17(1). e13090–e13090. 6 indexed citations

Uraki, Ryuta, Maki Kiso, Masaki Imai, et al.. (2022). Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters. Nature Microbiology. 7(8). 1252–1258. 22 indexed citations

Sato, Masatoki, Emi Takashita, Masahiko Katayose, et al.. (2021). Detection of Variants With Reduced Baloxavir Marboxil and Oseltamivir Susceptibility in Children With Influenza A During the 2019–2020 Influenza Season. The Journal of Infectious Diseases. 224(10). 1735–1741. 16 indexed citations

Ison, Michael G., Frederick G. Hayden, Alan Hay, et al.. (2021). Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group. Antiviral Research. 194. 105158–105158. 24 indexed citations

Takashita, Emi, Rod S. Daniels, Seiichiro Fujisaki, et al.. (2020). Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017–2018. Antiviral Research. 175. 104718–104718. 86 indexed citations

10.

Sato, Masatoki, Emi Takashita, Masahiko Katayose, et al.. (2020). Detection of Variants With Reduced Baloxavir Marboxil Susceptibility After Treatment of Children With Influenza A During the 2018–2019 Influenza Season. The Journal of Infectious Diseases. 222(1). 121–125. 26 indexed citations

11.

Yasuhara, Atsuhiro, Seiya Yamayoshi, Chiharu Kawakami, et al.. (2017). Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies. Scientific Reports. 7(1). 17735–17735. 20 indexed citations

12.

Gubareva, Larisa V., Terry G. Besselaar, Rod S. Daniels, et al.. (2017). Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016. Antiviral Research. 146. 12–20. 85 indexed citations

13.

Takashita, Emi, Seiichiro Fujisaki, Masayuki Shirakura, et al.. (2016). Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016. Eurosurveillance. 21(24). 25 indexed citations

14.

Fujisaki, Seiichiro, Masaki Imai, Emi Takashita, et al.. (2013). Mutations at the monomer–monomer interface away from the active site of influenza B virus neuraminidase reduces susceptibility to neuraminidase inhibitor drugs. Journal of Infection and Chemotherapy. 19(5). 891–895. 9 indexed citations

15.

Kishida, Noriko, Masaki Imai, Seiichiro Fujisaki, et al.. (2013). Seroprevalence of a Novel Influenza A (H3N2) Variant Virus in the Japanese Population. Japanese Journal of Infectious Diseases. 66(6). 549–551. 4 indexed citations

16.

Uraki, Ryuta, Maki Kiso, Kiyoko Iwatsuki‐Horimoto, et al.. (2013). A Novel Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice from Pandemic H1N1 and Highly Pathogenic H5N1 Virus Challenges. Journal of Virology. 87(14). 7874–7881. 25 indexed citations

17.

Takashita, Emi, Seiichiro Fujisaki, Noriko Kishida, et al.. (2013). Characterization of neuraminidase inhibitor‐resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post‐pandemic periods in Japan. Influenza and Other Respiratory Viruses. 7(6). 1390–1399. 23 indexed citations

18.

Matsuzaki, Yoko, Katsumi Mizuta, Yoko Aoki, et al.. (2010). A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir. Virology Journal. 7(1). 53–53. 53 indexed citations

19.

Matsuzaki, Yoko, Katsumi Mizuta, Emi Takashita, et al.. (2010). Comparison of virus isolation using the Vero E6 cell line with real-time RT-PCR assay for the detection of human metapneumovirus. BMC Infectious Diseases. 10(1). 170–170. 16 indexed citations

20.

Okamoto, Michiko, Kanetsu Sugawara, Emi Takashita, et al.. (2009). Development and evaluation of a whole virus-based enzyme-linked immunosorbent assay for the detection of human metapneumovirus antibodies in human sera. Journal of Virological Methods. 164(1-2). 24–29. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact